HU-211

URI: https://gptkb.org/entity/HU-211
GPTKB entity
Statements (30)
Predicate Object
gptkbp:instanceOf synthetic cannabinoid
gptkbp:alsoKnownAs Dexanabinol
gptkbp:CASNumber 112924-01-3
gptkbp:chemicalFormula C24H38O3
gptkbp:clinicalTrialPhase true
gptkbp:developedBy gptkb:Hebrew_University_of_Jerusalem
gptkb:Raphael_Mechoulam
gptkbp:doesNotBind gptkb:CB1_receptor
gptkb:CB2_receptor
gptkbp:drugClass NMDA receptor antagonist
neuroprotective agent
gptkbp:firstSynthesized 1988
gptkbp:hasNoPsychoactiveEffects true
https://www.w3.org/2000/01/rdf-schema#label HU-211
gptkbp:isomerOf gptkb:HU-210
gptkbp:IUPACName (6aR,10aR)-3-(2-methyloctan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
gptkbp:legalStatus uncontrolled (in most countries)
gptkbp:molecularWeight 374.56 g/mol
gptkbp:PubChem_CID 3083546
CHEMBL2104017
gptkbp:relatedTo gptkb:tetrahydrocannabinol
cannabidiol
gptkbp:routeOfAdministration oral
intravenous
gptkbp:studiedBy gptkb:trauma
stroke
neurodegenerative diseases
gptkbp:UNII 6J8XW7C6ZZ
gptkbp:bfsParent gptkb:HU-210
gptkbp:bfsLayer 8